Peregrine,
Glad to see you ask the question .... and get a solid, timely answer in response.
Seems clear from the recent 10K that, besides Xooma fiddling around with product packaging, it appears Xooma is actually waiting on HEPI to get its production capabilities up before going full bore on the marketing front.
Multiple components and challenges to that.
1. Moving to a bigger grow space.
2. Tidbit from 10K .... We have also completed the necessary testing to increase our production capabilities in order to meet the minimum distribution requirements under our exclusive distribution agreement. Research has determined that our grow cycle, previously thought to be 30 days, can be shortened to 15 days with the same quality and bioactive results, resulting in the ability to double our production. This is a significant event here .... reducing the grow/harvest time in half ... while maintaining product effectiveness. Of course the only way HEPI could possibly know this is if they spent time producing PAZ on multiple harvest cycles and then providing the material to WSU for testing. In order for HEPI to produce product under a different grow/harvest cycle, they damn sure need to know it works. I'd estimate this undertaking would have been a 2-3 month process at minimum as all these tests would have to be replicated to determine if the results are steady and repeatable.
3. Growing/creating new algae cultures to put in new/more tanks.
4. Money .... obviously the latest Xooma order has been delayed by Xooma for bottle decisions (9940 bottles) .... but that is money that could be used for moving things along like buying more growing equipment. Money has always been tight. Regardless, I'd still expect those funding HEPI to make sure the move, ID and tests are seen through to completion. According to the 10K there are still quite a few cheap warrants out there that could be exercised to fund HEPI current activities.
The company has come too far now to not see it through. Its been a slow and painful process but I think HEPI is close to getting it done.
Now if we could only get punchy and Baer ... I mean the sellers .... to stop selling. IMO, if HEPI does have a molecule discovery and method of action discovery for cholesterol mgmt ..... the stock is worth multiples of current price .... and that does not include the separate and bigger target of inflammation.
Amigo Mike
News 
Market Data 
Discover 
